Matricellular proteins as regulators of cancer metastasis to bone

Abstract

Metastasis is the major cause of the death in cancer patients, and a frequent site of metastasis for many cancers is the bone marrow. Therefore, understanding the mechanisms underlying the metastatic process is necessary for future prevention and treatment. The tumor microenvironment is now known to play a role in the metastatic cascade, both at the primary tumor and in metastatic sites, and includes both cellular and non-cellular components. The extracellular matrix (ECM) provides structural support and signaling cues to cells. One particular group of molecules associated with the ECM, known as matricellular proteins, modulate multiple aspects of tumor biology, including growth, migration, invasion, angiogenesis and metastasis. These proteins are also important for normal function in the bone by regulating bone formation and bone resorption. Recent studies have described a link between some of these proteins and metastasis of various tumors to the bone. The aim of this review is to summarize what is currently known about matricellular protein influence on bone metastasis. Particular attention to the contribution of both tumor cells and non-malignant cells in the bone has been given.

IGF-I/EGF and E2 signaling crosstalk through IGF-IR conduit point affects breast cancer cell adhesion

“…The interaction of the cells with their microenvironment, the extracellular matrix (ECM), is a critical step in carcinogenesis [4,5]. Moreover, accumulating evidence indicates that ECM components are strongly involved in the processes of cancer metastasis [6].…”

Cancer-associated Fibroblasts Release Exosomal CBFB That Dictate an Aggressive Bone Metastasis Phenotype in Breast Cancer 

“…A wealth of evidence supports the metastasis-promoting function of CXCR4 signaling [29,30]. An increased level of OPN in tumor cells and tissues has been shown to predict a higher incidence of bone metastasis [31]. Similarly, Runx2…”

Extracellular matrix: The driving force of mammalian diseases

“…Finally, one of the most unforgiving diseases affecting almost every organ system is that of cancer. These malignancies often start as an insult at the cellular level, progressing to unrestrained cellular proliferation, neovascularization, and metastasis [79]. As such, the ECM has become a hot subject of inquiry for drug discovery and therapeutic design to fight various types of cancer ranging from breast to lung to brain.…”